Akorn files abbreviated application for FDC

November 1, 2006

Buffalo Grove, IL-Akorn Inc. has submitted the first abbreviated new drug application with the Office of Generic Drugs on behalf of FDC Ltd., India's second-largest manufacturer and marketer of ophthalmic pharmaceutical products.

Buffalo Grove, IL-Akorn Inc. has submitted the first abbreviated new drug application with the Office of Generic Drugs on behalf of FDC Ltd., India's second-largest manufacturer and marketer of ophthalmic pharmaceutical products.

The proposed drug is an ophthalmic solution that FDC will manufacture in a blow-fill-seal container closure system.